We are live on ! Find out more
CNLM

CB PHARMA ACQUISISTION CORP SHS (CYM)
CNLM

Delisted

CNLM was delisted on the 8th of June, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in CB PHARMA ACQUISISTION CORP SHS (CYM) in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $18.4M → $0 (-$18.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
–
Holders Change
-8
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$5.55M
2
WAM
Weiss Asset Management
Massachusetts
-$4.28M
3
AA
AQR Arbitrage
Connecticut
-$3.54M
4
DKCM
Davidson Kempner Capital Management
New York
-$3.54M
5
KIM
Karpus Investment Management
New York
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
– -$5.55M -550,000 Closed
WAM
2
Weiss Asset Management
Massachusetts
– -$4.28M -423,246 Closed
AA
3
AQR Arbitrage
Connecticut
– -$3.54M -350,000 Closed
DKCM
4
Davidson Kempner Capital Management
New York
– -$3.54M -350,000 Closed
KIM
5
Karpus Investment Management
New York
– -$1.33M -131,601 Closed
YCM
6
Yakira Capital Management
Connecticut
– -$126K -12,500 Closed
TRCT
7
Tower Research Capital (TRC)
New York
– -$3K -303 Closed

CNLM Hedge Fund Activity: Q2 2016 in Review

0 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) for Q2 2016, worth a combined $0 — down 100% from $18.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CNLM and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $5.55M sold.

  • 0 institutional investors held CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) as of Q2 2016, down from 8 in Q1 2016.
  • Funds reported $0 of CB PHARMA ACQUISISTION CORP SHS (CYM) stock for Q2 2016, down 100% quarter-over-quarter.
  • 0 funds opened new CB PHARMA ACQUISISTION CORP SHS (CYM) positions in Q2 2016 and 8 closed out, a net change of -8 holders.
  • The largest CB PHARMA ACQUISISTION CORP SHS (CYM) seller in Q2 2016 was Polar Asset Management Partners, an estimated $5.55M sold.

Based on aggregated 13F filings for Q2 2016.